Immunology, Antimicrobial Mechanisms, and Immunomodulation

Comprehensive guide covering immunomodulation covering innate and adaptive immunity, cytokine modulation, and immunostimulant versus immunomodulatory actions. Western immunology, antimicrobial pharmacology, phytochemical immune mechanisms.

---

Table of Contents

1. Foundational Immunology
2. Elderberry: Antiviral Mechanisms
3. Echinacea: Immunomodulation Science
4. Garlic: Antimicrobial Biochemistry
5. Synergistic Formulation Strategies
6. Clinical Evidence and Application

---

Foundational Immunology

The Immune System: Two-Tiered defence

Innate Immunity (First Line, Non-Specific):

Physical barriers:

• Skin (mechanical barrier, antimicrobial peptides)
• Mucous membranes (trap pathogens, secretory IgA)
• Ciliary action (respiratory tract clearance)
• Gastric acid (destroys ingested pathogens)

Cellular components:

• Macrophages: “Big eaters” – phagocytose (engulf) pathogens, present antigens, secrete cytokines
• Neutrophils: Most abundant white blood cells, first responders, phagocytic, release antimicrobial compounds
• Natural Killer (NK) cells: Destroy virus-infected and tumor cells without prior sensitisation
• Dendritic cells: “Sentinel cells” – capture antigens, migrate to lymph nodes, activate adaptive immunity

Soluble components:

• Complement system: Cascade of proteins that mark pathogens for destruction, create membrane attack complex
• Acute phase proteins: C-reactive protein, mannose-binding lectin
• Interferons: Antiviral proteins that induce “antiviral state” in neighboring cells

Timeline: Minutes to hours

Adaptive Immunity (Second Line, Specific):

Cellular (T-cell mediated):

• Helper T cells (CD4+):
• Th1 cells: Activate macrophages, support cellular immunity (intracellular pathogens) – Th2 cells: Support antibody production, fight parasites and allergens – Balance between Th1/Th2 critical for appropriate immune response
• Cytotoxic T cells (CD8+): Directly kill infected cells
• Regulatory T cells: Prevent excessive immune responses, maintain self-tolerance

Humoral (B-cell/Antibody mediated):

• B cells: Produce antibodies specific to pathogens
• Antibody classes:
• IgM: First response, largest antibody – IgG: Most abundant, crosses placenta, long-term immunity – IgA: Found in secretions (saliva, tears, mucus), prevents pathogen attachment – IgE: Allergic responses, parasite defence

Memory: Both T and B cells form memory populations for rapid response upon re-exposure

Timeline: Days to weeks for initial response; hours for memory response

Cytokines: Immune Communication Molecules

Pro-inflammatory cytokines:

• TNF-α (Tumor Necrosis Factor-alpha): Fever, inflammation, activates neutrophils and macrophages
• IL-1 (Interleukin-1): Fever, acute phase response, T-cell activation
• IL-6: Fever, acute phase proteins, stimulates antibody production
• IL-12: Drives Th1 response, activates NK cells

Anti-inflammatory cytokines:

• IL-10: Suppresses inflammatory responses, prevents excessive tissue damage
• TGF-β: Regulatory functions, tissue repair

Antiviral:

• Type I Interferons (IFN-α, IFN-β): Induce antiviral state in cells, activate NK cells
• Type II Interferon (IFN-γ): Activates macrophages, enhances antigen presentation

Balance is key: Appropriate cytokine response fights infection; excessive response causes tissue damage (“cytokine storm”)

Viral Replication Cycle (Target for Herbal Interventions)

1. Attachment: Virus binds to host cell receptors via surface glycoproteins (e.g., hemagglutinin in influenza)

2. Entry: Virus enters cell through membrane fusion or endocytosis

3. Uncoating: Viral genetic material released into cytoplasm

4. Replication: Viral genome replicated using host cell machinery

5. Assembly: New viral particles assembled

6. Release: New viruses exit cell (often via budding, using neuraminidase to cleave from cell surface)

Herbal interventions can occur at multiple stages:

• Block attachment (elderberry)
• Prevent entry (various antiviral herbs)
• Inhibit replication (some polyphenols)
• Prevent release (neuraminidase inhibitors)

---

Elderberry: Antiviral Mechanisms

Phytochemical Profile

Anthocyanins (Primary Actives):

Elderberries contain exceptionally high anthocyanin content (up to 1,600 mg/100g fresh berries), giving them their deep purple colour.

Major anthocyanins:

• Cyanidin 3-glucoside (Cy-3-glu): Most abundant
• Cyanidin 3-sambubioside (Cy-3-sam): Unique to elderberry
• Cyanidin 3-sambubioside-5-glucoside
• Cyanidin 3,5-diglucoside

Other bioactive compounds:

• Flavonols: Quercetin derivatives, rutin
• Phenolic acids: Chlorogenic acid, caffeic acid derivatives
• Triterpenes: Ursolic acid, oleanolic acid

Mechanism 1: Hemagglutinin Inhibition

The viral surface spike:

Influenza viruses have hemagglutinin (HA) glycoprotein spikes on their surface. HA binds to sialic acid residues on host cell membranes, initiating infection.

Elderberry’s action:

Research demonstrates that elderberry anthocyanins bind directly to hemagglutinin spikes, causing:

1. Denaturation: Structural changes in HA protein
2. Blocked binding sites: Prevents HA from attaching to sialic acid receptors
3. Viral inactivation: Virus cannot penetrate cells

Scientific evidence:

• Elderberry extract inhibited hemagglutination in laboratory assays
• Blocked viral attachment to erythrocytes (red blood cells)
• Effective against multiple influenza strains (H1N1, H3N2, influenza B)

Result: Virus cannot initiate infection

Mechanism 2: Neuraminidase Inhibition

The viral release enzyme:

After viruses replicate inside cells, neuraminidase (NA) cleaves sialic acid bonds, allowing new viruses to bud from the cell surface and spread to infect other cells.

Elderberry’s action:

Cyanidin 3-sambubioside specifically binds to influenza neuraminidase:

Molecular binding:

• Attaches to NA active site residues 356-364 and 395-432
• Blocks specific segments of the enzyme
• Shields proteases from releasing these peptide segments
• Novel binding mode not seen with pharmaceutical NA inhibitors (oseltamivir/Tamiflu)

Effect: Prevents viral release and propagation to other cells

Clinical significance:

• Reduces viral load
• Limits spread within respiratory tract
• Decreases symptom severity

Note: This dual action (blocking entry AND release) makes elderberry particularly effective.

Mechanism 3: Multi-Stage Viral Inhibition

University of Sydney research (Torabian et al., 2019):

Comprehensive study using commercially farmed elderberries against influenza A virus demonstrated:

Pre-infection treatment:

• Applied elderberry before virus exposure
• Blocked viral entry into cells
• Significant inhibitory effect

During infection:

• Applied elderberry during active infection
• Reduced viral replication
• Moderate effect

Post-infection (most surprising finding):

• Applied elderberry AFTER cells already infected
• Even more effective than early treatment
• Blocked viral propagation at later stages
• Prevented transmission to neighboring cells

Mechanism explanation:

• Early stage: Blocks hemagglutinin (entry)
• Late stage: Inhibits neuraminidase (release) more potently
• Works at multiple points in viral life cycle

Clinical implication: Elderberry effective even if not taken at first symptom — still beneficial during active infection.

Mechanism 4: Immunomodulation

Cytokine effects:

Elderberry influences immune signaling, though effects are complex:

Stimulatory effects:

• Increases production of IL-6, IL-8, TNF-α in some studies
• Enhances inflammatory response to clear infection
• Activates immune cells

Anti-inflammatory effects:

• Other studies show reduction in pro-inflammatory cytokines
• Prevents excessive inflammation
• Balances immune response

Current understanding:

• Context-dependent effects
• May enhance appropriate immune response while preventing excessive inflammation
• Polysaccharide and anthocyanin components have different immunological effects

Practical outcome: Supports effective immune response without causing cytokine storm.

Clinical Evidence

Meta-analysis (Hawkins et al., 2019):

Analysis of 4 randomised controlled trials, 180 participants total:

Primary finding:

• Large effect size (1.717, P<0.001)
• Elderberry substantially reduced duration of upper respiratory symptoms

Influenza-specific:

• Effect size 2.074 (very large effect)
• Average reduction: 2-4 days symptom duration
• More effective against flu than common cold (cold ES: 0.662)

Safety:

• No significant adverse effects reported
• Well-tolerated across all studies

Zakay-Rones studies (1995, 2004):

Used standardised elderberry extract (Sambucol, 1,900 mg anthocyanins daily):

1995 study (Influenza B outbreak):

• 93% of elderberry group complete symptom relief in 2 days
• Placebo group: 6 days for symptom relief

2004 study (Influenza A and B):

• Symptoms relieved 4 days earlier on average
• Less need for rescue medication

Active compounds dose-dependent:

• Higher anthocyanin content = better results
• Standardisation important for clinical effect

Bioavailability and Metabolism

Absorption:

Anthocyanins absorbed in small intestine:

• Peak plasma levels 1-2 hours after ingestion
• Relatively low bioavailability (individual anthocyanins 0.1-1%)
• Metabolites more abundant than parent compounds

Gut microbiome role:

Unabsorbed anthocyanins reach colon where gut bacteria metabolise them into:

• Phenolic acid metabolites (protocatechuic acid, others)
• These metabolites may contribute significantly to biological activity
• Persist longer in circulation than parent anthocyanins

Implications:

• Regular dosing maintains active compounds and metabolites
• Effects are systemic, not just local to respiratory tract
• Individual microbiome may influence effectiveness

---

Echinacea: Immunomodulation Science

Phytochemical Complexity

Three primary constituent classes:

1. Alkamides (Alkylamides):

Structure: Long-chain fatty acid derivatives with nitrogen-containing groups

Primary alkamides in Echinacea:

• Dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamide
• Undeca-2E,4Z-diene-8,10-diynoic acid isobutylamide
• Multiple others (>20 identified)

Location: Concentrated in roots; lesser amounts in aerial parts

Solubility: Lipophilic (fat-soluble); extracted well by alcohol, poorly by water

Sensation: Cause tingling sensation on tongue when consuming fresh echinacea

2. Caffeic Acid Derivatives:

Major compounds:

• Cichoric acid (Chicoric acid): Most abundant in E. purpurea aerial parts
• Echinacoside: Found primarily in E. angustifolia and E. pallida roots
• Chlorogenic acid: Present in all species

Properties:

• Hydrophilic (water-soluble)
• Potent antioxidants
• Anti-inflammatory

3. Polysaccharides:

Types:

• Arabinogalactans
• Arabinoxylans
• Inulin-type fructans

Characteristics:

• High molecular weight
• Water-soluble
• Extracted by aqueous preparations (teas, fresh juice)

Immunomodulation Mechanisms

Mechanism 1: Macrophage Activation

Macrophages are key innate immune cells that:

• Phagocytose (engulf and destroy) pathogens
• Present antigens to activate adaptive immunity
• Secrete cytokines to coordinate immune response

Echinacea’s effects on macrophages:

Enhanced phagocytosis:

• Alkamides and polysaccharides increase rate at which macrophages engulf particles
• Water-ethanol extracts containing chicoric acid, polysaccharides, and alkamides increased macrophage phagocytic activity in rats
• Higher concentrations → greater activity
• Carbon clearance test (mice): Enhanced removal of foreign particles from bloodstream

Increased nitric oxide (NO) production:

• Spleen macrophages from echinacea-treated rats show increased NO release when stimulated
• NO has antimicrobial properties
• Involved in inflammatory signaling

Mechanism:

• Alkamides may interact with cannabinoid receptors (CB2) on immune cells
• Polysaccharides bind to pattern recognition receptors (Toll-like receptors)
• Activates intracellular signaling cascades
• Increases expression of immune-related genes

Mechanism 2: Natural Killer Cell Enhancement

NK cells are innate immune cells that:

• Identify and destroy virus-infected cells
• Kill tumor cells
• Don’t require prior sensitisation (unlike T cells)

Echinacea’s effects:

Increased NK cell numbers:

• Oral administration of E. purpurea root extract increased NK cells in normal, leukemic, and aging mice

Enhanced cytotoxicity:

• NK cells from echinacea-treated animals more effective at killing target cells
• Increased release of perforin and granzymes (cytotoxic molecules)

Clinical relevance: More rapid elimination of virus-infected cells before viral replication spreads.

Mechanism 3: Cytokine Production

Pro-inflammatory cytokines (infection-fighting):

Echinacea polysaccharides stimulate macrophages to produce:

• IL-1: Fever, inflammation, T-cell activation
• IL-6: Acute phase response, antibody production
• TNF-α: Activates neutrophils, enhances inflammation

Mechanism: Polysaccharides bind to macrophage surface receptors → activation of transcription factors (NF-κB) → increased cytokine gene expression

Timing importance: Enhanced cytokine production beneficial at infection onset; excessive or prolonged production harmful

Mechanism 4: Interferon Stimulation

Interferons are crucial antiviral molecules.

Echinacea’s effects:

• Stimulates production of Type I interferons (IFN-α, IFN-β)
• Alkamides and caffeic acid derivatives activate interferon pathways

Antiviral mechanism:

• Interferons bind to neighboring cell receptors
• Induce “antiviral state” in cells
• Upregulate enzymes that degrade viral RNA
• Inhibit protein synthesis needed for viral replication

Result: Cells become resistant to viral infection before virus spreads.

Mechanism 5: Dendritic Cell Modulation

Dendritic cells (DCs) bridge innate and adaptive immunity:

• Capture antigens
• Migrate to lymph nodes
• Present antigens to T cells (initiates adaptive response)

Echinacea’s complex effects:

Polysaccharides (aqueous extracts):

• Activate DCs
• Increase expression of co-stimulatory molecules
• Enhance DC ability to activate T cells

Alkamides (ethanolic extracts):

• May suppress DC function in some contexts
• Potentially prevent over-activation
• Context and dose-dependent

Interpretation: Different preparations (water vs. alcohol) have different DC effects. May contribute to echinacea’s ability to enhance immunity without causing excessive inflammation.

Antimicrobial Mechanisms

Beyond immunomodulation, echinacea has direct effects on pathogens:

Cell membrane disruption:

• Alkamides are lipophilic
• Integrate into microbial lipid bilayers
• Increase membrane permeability
• Cause cell lysis and death

Enzyme inhibition:

• Caffeic acid derivatives inhibit microbial enzymes
• Affects cell wall synthesis
• Disrupts nucleic acid production

Antiviral activity:

• Inhibits influenza hemagglutination
• Active against HSV-1, HSV-2, influenza A and B
• Blocks viral entry in some cases

Species and Part Differences

Chemical composition varies significantly:

E. purpurea (Purple Coneflower):

• High cichoric acid in aerial parts
• Moderate alkamides in roots
• Most researched species
• Often used as fresh pressed juice or dried herb

E. angustifolia (Narrow-Leaf Coneflower):

• High echinacoside in roots
• Higher alkamide content than E. purpurea
• Traditional Native American medicine
• Often used as root tincture

E. pallida (Pale Purple Coneflower):

• High echinacoside
• Different alkamide profile
• Less commonly used

Aerial parts vs. roots:

• Aerial parts: Higher caffeic acid derivatives (especially cichoric acid)
• Roots: Higher alkamides
• Both have polysaccharides

Extraction method matters:

• Aqueous (tea, fresh juice): Polysaccharides, some phenolics
• Alcoholic (tincture): Alkamides, phenolics
• Combined extracts may offer synergistic benefits

Clinical Evidence

Meta-analyses and systematic reviews:

Cochrane Review:

• Identified multiple trials with mixed results
• Quality of studies variable
• Product standardisation major issue

Consistent findings across studies:

• May reduce incidence of colds (preventative use)
• More effective at onset of symptoms
• Reduces symptom duration by ~1-2 days on average
• Effects modest but significant

Key challenges in research:

• Product variability (different species, parts, extracts)
• Lack of standardisation
• Dosing differences
• Timing of administration

Studies with positive results typically used:

• Fresh plant preparations or standardised extracts
• Adequate alkamide and/or polysaccharide content
• Early intervention (first 24-48 hours)
• Sufficient dosing (300-500mg extract 3x daily minimum)

Pharmacokinetics

Alkamide absorption:

• Rapidly absorbed from GI tract
• Peak plasma levels 30 minutes to 2 hours
• Accumulate in tissues
• Half-life approximately 3-6 hours
• Metabolised primarily in liver

Clinical implication: Frequent dosing (every 2-3 hours) maintains therapeutic levels during acute infection.

Polysaccharide absorption:

• Large molecules, minimal absorption intact
• Effects primarily through gut-associated lymphoid tissue (GALT)
• Activate immune cells in intestinal mucosa
• Systemic immunomodulation without systemic absorption

---

Garlic: Antimicrobial Biochemistry

Organosulfur Chemistry

The Allicin Pathway:

Garlic’s antimicrobial power comes from organosulfur compounds formed when garlic is crushed:

1. Intact garlic clove contains:

• Alliin (S-allyl-L-cysteine sulfoxide): Stable, odorless precursor
• Alliinase enzyme: Stored in separate compartments

2. When crushed:

• Cell damage brings alliin and alliinase together
• Alliinase converts alliin → allicin (diallyl thiosulfinate)
• Reaction occurs rapidly (seconds to minutes)
• Allicin is responsible for characteristic pungent odor

3. Allicin instability:

• Allicin degrades quickly (half-life minutes at room temp, hours when refrigerated)
• Breaks down into multiple sulfur compounds:
• Diallyl sulfide (DAS) – Diallyl disulfide (DADS) – Diallyl trisulfide (DATS) – Ajoene (formed in oil) – Vinyldithiins

Why crushing and waiting matters:

• Maximum allicin formation requires 10 minutes after crushing
• Cooking immediately after crushing destroys alliinase before allicin forms
• For maximum benefit: Crush → wait 10 minutes → consume raw or add to food after cooking

Antimicrobial Mechanisms

Broad-spectrum activity:

Garlic compounds effective against:

• Gram-positive bacteria (Staphylococcus, Streptococcus)
• Gram-negative bacteria (E. coli, Salmonella)
• Fungi (Candida, Aspergillus)
• Viruses (influenza, rhinovirus, herpes)
• Parasites

Mechanism 1: Thiol-Disulfide Exchange

Allicin chemistry:

• Highly reactive due to sulfur-sulfur bond
• Reacts with thiol (-SH) groups in proteins
• Particularly targets cysteine residues

Effect on microbes:

• Modifies essential microbial enzymes
• Disrupts protein folding
• Inhibits DNA and RNA synthesis
• Damages cell membranes
• Multiple targets → difficult for resistance to develop

Example:

• Allicin inhibits cysteine proteases essential for microbial metabolism
• Inactivates enzymes involved in lipid synthesis
• Disrupts energy production pathways

Mechanism 2: Oxidative Stress

Reactive oxygen species (ROS):

• Allicin and derivatives generate ROS in microbial cells
• Overwhelms antioxidant defences
• Causes oxidative damage to:
• DNA (mutations, strand breaks) – Proteins (oxidation of amino acids) – Lipids (membrane peroxidation)

Selective toxicity:

• Higher concentrations needed to damage human cells
• Therapeutic window exists
• Microbes more susceptible than host cells

Mechanism 3: Membrane Disruption

Lipophilic compounds (ajoene, diallyl sulfides):

• Integrate into lipid bilayers
• Increase membrane fluidity
• Disrupt membrane integrity
• Cause leakage of cellular contents

Effect:

• Loss of membrane potential
• Disrupted ion gradients
• Cell death

Antiviral Mechanisms

Activity against respiratory viruses:

Research demonstrates garlic effectiveness against:

• Influenza A and B
• Rhinovirus (common cold)
• RSV (respiratory syncytial virus)
• Herpes simplex virus

Mechanisms:

Viral entry inhibition:

• Garlic compounds interfere with viral attachment proteins
• Block virus-cell membrane fusion
• Prevent viral penetration into cells

Replication inhibition:

• Some organosulfur compounds inhibit viral polymerases
• Interfere with viral protein synthesis
• Reduce viral yield in infected cells

Immune enhancement:

• Stimulates NK cell activity
• Enhances macrophage function
• Increases interferon production

Clinical evidence:

• Supplementation reduces cold incidence
• Decreases symptom severity
• Shortens illness duration (1-2 days average)

Immunomodulation

Enhanced immune cell function:

Macrophages and neutrophils:

• Increased phagocytosis
• Enhanced respiratory burst (antimicrobial ROS production)
• Improved chemotaxis (migration to infection site)

NK cells:

• Increased cytotoxicity against virus-infected cells
• Higher NK cell numbers with regular garlic consumption

T-cell proliferation:

• Aged garlic extract stimulates T-cell production
• Enhances cell-mediated immunity

Cytokine modulation:

• Increases IL-2 (T-cell growth factor)
• Enhances IFN-γ production (Th1 response)
• May reduce excessive pro-inflammatory cytokines in some contexts

Preparation and Bioavailability

Raw vs. Cooked:

Raw garlic:

• Maximum allicin and derivatives
• Strongest antimicrobial activity
• Most pungent

Cooked garlic:

• Heat destroys alliinase
• If crushed and waited 10 minutes before cooking, some allicin formed and converts to stable compounds
• Less antimicrobial activity than raw
• Still provides some organosulfur compounds and other benefits

Aged garlic extract:

• Fermented garlic
• Contains S-allyl cysteine (SAC) and other water-soluble compounds
• No allicin
• Different biological properties (cardiovascular, antioxidant)
• Milder, less antimicrobial activity than fresh
• More tolerable for long-term use

Garlic oil:

• Oil-soluble compounds (ajoene, diallyl sulfides)
• Different spectrum of activity
• Effective against some pathogens

Optimal for immune support:

• Fresh, raw garlic
• Crushed and waited 10 minutes
• Consumed regularly during high-risk periods

---

Synergistic Formulation Strategies

Understanding Synergy

Types of herb interactions:

Additive: 1 + 1 = 2 (combined effect equals sum of individual effects)

Synergistic: 1 + 1 = 3+ (combined effect greater than sum)

Antagonistic: 1 + 1 = 1 or less (one herb reduces another’s effectiveness)

Mechanisms of synergy:

• Multi-target effects (herbs act at different points in disease process)
• Enhanced bioavailability (one herb improves absorption of another)
• Complementary mechanisms (different immune pathways activated)
• Reduced side effects (lower doses needed when combined)

Example Synergistic Combination: Elderberry + Echinacea

Complementary mechanisms:

Elderberry:

• Direct antiviral (blocks hemagglutinin and neuraminidase)
• Works at entry and release stages of viral cycle
• Immunomodulatory (cytokine effects)

Echinacea:

• Immunostimulant (enhances macrophage, NK cell activity)
• Increases interferon production
• Some direct antiviral effects
• Anti-inflammatory (alkamides)

Combined effect:

1. Elderberry prevents viral entry and spread
2. Echinacea activates immune cells to destroy viruses that do enter
3. Echinacea’s interferon stimulation makes cells resistant to infection
4. Elderberry’s cytokine modulation + echinacea’s anti-inflammatory effects balance immune response

Clinical support:

• Combination products widely used
• Anecdotal reports suggest better outcomes than single herb
• No formal studies comparing combination vs. single herbs

Multi-Herb Formulation Principles

Building comprehensive immune formula:

1. Antiviral component (choose 1-2):

• Elderberry (primary)
• Lemon balm (anti-herpes, anti-influenza)
• Licorice (antiviral glycyrrhizin)

2. Immunostimulant (choose 1-2):

• Echinacea (acute use)
• Astragalus (preventative, long-term)
• Medicinal mushrooms (beta-glucans)

3. Antimicrobial (choose 1-2):

• Garlic (broad-spectrum)
• Thyme (respiratory focus)
• Oregano (strong antimicrobial)

4. Circulatory stimulant (choose 1):

• Ginger (drives herbs, warming)
• Cayenne (very warming, circulatory)

5. Demulcent/soothing (optional, for symptom relief):

• Marshmallow root (soothes throat and respiratory)
• Licorice (soothing, antiviral)
• Mullein (expectorant, lung tonic)

Dosing considerations:

• Lower doses of each herb when combining
• Monitor for interactions
• Start with 2-3 herbs before adding more

---

Clinical Evidence and Application

Evidence Levels

Level 1: Systematic reviews and meta-analyses

• Elderberry: Multiple meta-analyses showing efficacy
• Echinacea: Mixed results, quality variable

Level 2: Randomised controlled trials

• Elderberry: Several high-quality RCTs
• Echinacea: Many RCTs, results variable based on preparation
• Garlic: Moderate evidence for cold prevention

Level 3: Observational studies

• Traditional use across cultures
• Clinical observations

Level 4: In vitro and animal studies

• Strong mechanistic evidence for most immune herbs
• Demonstrates biological plausibility

Translating Research to practise

Challenges:

Product variability:

• Different species, plant parts, extraction methods
• Lack of standardisation in many studies
• Commercial products vary widely in active constituents

Dosing:

• Research doses often higher than commercial product recommendations
• Effective dose-response relationships not always clear

Timing:

• Critical factor often underemphasised
• Early intervention typically more effective

Individual variation:

• Genetics (cytochrome P450 polymorphisms affect metabolism)
• Microbiome (influences metabolism and absorption)
• Immune status (immunocompromised vs. healthy)
• Age (elderly may respond differently)

Evidence-Based Protocols

Prevention Protocol (Autumn-Winter):

Daily baseline:

• Garlic: 1-2 raw cloves in food
• Medicinal mushrooms or astragalus: Daily dose as per product
• Vitamin D: Essential for immune function (especially NZ winter)
• Sleep: 7-9 hours

When exposure increases (sick coworkers, family, travel):

• Add echinacea: 2 weeks on, 1 week off cycles
• Increase garlic to 2-3 cloves
• Fire cider: 1 tablespoon daily

Acute Intervention Protocol (First 24-48 Hours):

Hour 0 (first symptom):

• Elderberry syrup: 1 tablespoon immediately
• Echinacea tincture: 4ml immediately
• Raw garlic: 2 cloves
• Rest begins NOW

Hours 2-4:

• Echinacea: 2-4ml every 2-3 hours (aggressive dosing)
• Hot ginger-lemon tea: Continuously sipping
• Elderberry: 1 tablespoon every 4 hours

Ongoing (Days 1-3):

• Maintain high-dose elderberry and echinacea
• Garlic: 3-4 cloves throughout day
• Thyme tea: 3-4 cups daily
• maximise rest, fluids, warmth

Days 4-7:

• Reduce to moderate doses
• Monitor symptoms
• Continue rest

Recovery:

• Taper to preventative doses
• Don’t stop abruptly
• Resume normal activities gradually

Safety and Contraindications

Elderberry:

• Very safe when cooked/processed
• Avoid raw berries (can cause nausea)
• Generally safe in pregnancy/lactation (cooked)

Echinacea:

• Generally safe short-term
• Possible concerns:
• Autoimmune conditions (theoretical risk of stimulation) – Allergic reactions in daisy/ragweed allergic individuals – May interact with immunosuppressants
• Avoid long-term continuous use (>8 weeks)

Garlic:

• Very safe as food
• High doses may cause:
• GI upset – Body odour – Mild blood thinning
• Interactions:
• Blood thinners (warfarin): Monitor INR – Antiplatelet drugs: Additive effects – HIV medications (saquinavir): Reduces drug levels

General principles:

• Inform healthcare providers of all herbs used
• Herbs support but don’t replace medical care
• More is not always better
• Quality and timing matter more than quantity

---

References

Barrett, B. (2003). Medicinal properties of Echinacea: A critical review. Phytomedicine, 10(1), 66-86.

Bone, K., & Mills, S. (2013). Principles and practice of phytotherapy: Modern herbal medicine (2nd ed.). Churchill Livingstone.

Hawkins, J., et al. (2019). Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomised, controlled clinical trials. Complementary Therapies in Medicine, 42, 361-365.

Hudson, J., & Vimalanathan, S. (2011). Echinacea — A source of potent antivirals for respiratory virus infections. Pharmaceuticals, 4(7), 1019-1031.

Percival, S.S. (2000). Use of echinacea in medicine. Biochemical Pharmacology, 60(2), 155-158.

Torabian, G., et al. (2019). Anti-influenza activity of elderberry (Sambucus nigra). Journal of Functional Foods, 54, 353-361.

Zakay-Rones, Z., et al. (1995). Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract during an outbreak of influenza B. Journal of Alternative and Complementary Medicine, 1(4), 361-369.

Zakay-Rones, Z., et al. (2004). Randomised study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections. Journal of International Medical Research, 32(2), 132-140.

---